“…Furthermore, novel treatments may be used alone or in combination with conventional therapies, such as the inhibition of QS and bacterial lectins, the use of iron chelation, phage therapy, vaccine strategies, as well as the use of nanoparticles, antimicrobial peptides and electrochemical scaffolds ( Chatterjee et al, 2016 ). In our previous study, the minimal inhibitory concentration (MIC) of EGCG against P. aeruginosa was confirmed to be 512 ÎŒg/ml ( Hao et al, 2021 ). However, EGCG reduced virulence phenotypes, such as biofilm, protease, elastase activity, swimming, and swarming motility at concentrations where no growth inhibition was observed.…”